Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
668 Leser
Artikel bewerten:
(2)

OPEX UK Innovation Centre Connects Customers Around the World to State-of-the-Industry Mail and Document Automation Solutions

Finanznachrichten News

MOORESTOWN, NJ / ACCESSWIRE / May 6, 2021 / OPEX Corporation, a leading provider of innovative warehouse, mail and document automation (DMA) solutions worldwide, has opened a new facility where customers may view and interact with OPEX technology that provides seamless mail opening and document imaging.

"The new UK Innovation Centre is a space to demonstrate the mail and document automation systems we offer so customers better understand how our technology benefits their business," said Shaun Lee, OPEX Director of Operations for Europe, Middle East and Africa (EMEA). "At present, we are providing demonstrations virtually and will open to in-person visits safely after COVID restrictions are eased."

Located in Bolton, Greater Manchester, England, the UK Innovation Centre is adjacent to existing OPEX office space and will be staffed on demand for demonstrations to potential customers, as well as to test, fine-tune and troubleshoot technology with existing customers and product resellers.

"Customers provide samples of the documents they need to digitise and automate, and we provide an in-depth, end-to-end demonstration of our solutions in action in an environment where things can be simulated to reflect the customer's actual environment," said Lee. "The UK Innovation Centre facility is also equipped with state-of-the-art video conferencing technology so customers can participate in demonstrations remotely from anywhere in the world."

OPEX's DMA solutions include seamless mail sorting, opening and document digitisation technologies designed to improve business workflow and throughput while significantly reducing or eliminating labour-intensive document prep.

"There has been a real growth spurt within the company over the last two years," said Scott Maurer, President, OPEX International. "We have been growing our facilities, talent, and infrastructure to meet the growing automation needs of our customers. The UK Innovation Centre is one more way we are evolving to give our customers the assistance they require."

As more businesses move to securely and efficiently digitise their paper documents, innovative OPEX solutions such as the Falcon® Scanner Series help customers easily process different thicknesses of paper, handle fragile or damaged documents without pre-sorting, and scan X-rays and three-dimensional objects, saving time and money. The technology ensures safe and secure document transformation that makes sense, guarding against costly data breaches.

Medical and personnel records are a large part of OPEX's document imaging customer base across the EMEA division. The National Health Service in the UK, Social Security in France, and private medical providers in Germany are prominent customers.

For more information about OPEX technology solutions in EMEA visit www.digitiseyourdocuments.co.uk or request a virtual demo by contacting DMA_EMEA@opex.com.

About

OPEX Corporation provides Next Generation Automation, including warehouse, document and mail automation solutions, to customers around the globe. With headquarters in Moorestown, NJ - and facilities in Pennsauken, NJ; Plano, TX (Dallas metro); France; Germany; Switzerland; and the United Kingdom - OPEX has more than 1,300 employees committed to reimagining and delivering innovative, scalable, unique technology solutions to solve the business challenges of today.

Media Contact:

Colleen Ciak
(856) 727-1100 x5350
cciak@opex.com

SOURCE: OPEX



View source version on accesswire.com:
https://www.accesswire.com/644928/OPEX-UK-Innovation-Centre-Connects-Customers-Around-the-World-to-State-of-the-Industry-Mail-and-Document-Automation-Solutions

© 2021 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.